Pharma continues to evolve in the way Medical Affairs engages with Healthcare Professionals (HCPs) and Key Opinion Leaders (KOLs). From a Medical Affairs perspective, the global upheaval of 2020-21 highlighted the importance of targeting the best stakeholders, knowing exactly how team members are engaging with those stakeholders, and maximizing the effectiveness of field-based medical teams.

As part of this introspection, top-tier Medical Affairs leaders are beginning to realize that they are likely not optimizing their effort if they have Medical Science Liaisons (MSLs) focused only on top KOLs. Looking forward, new roles and new ways of targeting promise to change the shape of  Medical Affairs.

Indeed, as the Amplity team listens to clients across the industry, we continue to identify communication gaps within Pharma’s customer-facing Medical teams. We have identified new and evolving targets for scientific communication that are beyond the scope of traditional MSLs. We are hearing a rising call for a new approach to fill those gaps, and it’s becoming clear that the time has come to apply a nimble approach to the design of customer-facing Medical teams. Download our eBook to learn more: https://bit.ly/3ksK6yE